Last reviewed · How we verify
NCT03061409
Vitamin and Mineral Supplementation Improves Micronutrient Status in Older Adults
NA trial testing Pharmavite Nature Made Multi for Him 50+ in Nutrient Deficiency in 54 participants. Completed in 15 March 2019.
15 March 2019
Quick facts
| Lead sponsor | Tufts University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 54 |
| Start date | 1 May 2016 |
| Primary completion | 15 March 2019 |
| Estimated completion | 15 March 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Pharmavite Nature Made Multi for Him 50+
- Placebo
Conditions studied
- Nutrient Deficiency — all drugs for Nutrient Deficiency →
Sponsor
Tufts University
Who can join
Adults 45 to 75, any sex, with Nutrient Deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Nutrient intake through diet and nutritional supplements are critical determinants of plasma nutrient status. In addition, untoward drug-nutrient can contribute to nutritional inadequacy. Among medications used by the elderly in the US, diuretics, metformin, and proton pump inhibitors (PPIs) are ranked among the most commonly prescribed. Use of these medications is variously associated with inadequate status of many micronutrients, e.g., vitamins B1, B9 (folate), B12, C, and thiamine and the minerals calcium, iron, potassium, magnesium, and zinc. While diets rich in whole grains, fruits, and vegetables can help decrease the risk for micronutrient inadequacy in older adults using one or more of these drugs, supplementation may prove more effective to restoring and/or enhancing their nutrient status. When compared to a placebo, investigators hypothesize that a multivitamin-multi-mineral (MVM) supplement will improve nutritional status in older adults at increased risk of micronutrient inadequacy induced by drugs commonly used by this population, specifically diuretics, metformin, and PPIs. Investigators also hypothesize that MVM supplementation will beneficially modify selected biomarkers or biochemical pathways of cellular function/health. To test these hypotheses, investigators will conduct a randomized clinical trial by pursuing the following specific aims: 1) To determine the extent by which MVM supplementation (compared to placebo) will increase the plasma status of vitamins B12, C, D, folic acid, and thiamine and the minerals iron, magnesium, potassium, and zinc; 2) To quantify indices of 'metabolic health' including one or more of the following biomarkers: glutathione (GSH)/glutathione disulfide (GSSG) ratio, ubiquinol/ubiquinone, malondialdehyde (MDA), asymmetric dimethyl arginine (ADMA), selected cytokines and chemokines, homocysteine, methylmalonic acid (MMA).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03061409
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Nutrient Deficiency
Currently open trials in the same condition.
- NCT07271316 — Alii Supplement Study · Phase 2 · recruiting
- NCT06835738 — Implementation of Multiple Micronutrient Supplementation (MMS) for Pregnant Women in Uganda · NA · recruiting
- NCT05608772 — Conversion to SADI-S, RYGB or OAGB After Failed Sleeve · NA · recruiting
- NCT06025786 — Impact Evaluation of Benazir Nashonuma Program (BNP) on Stunting Among Under-five Children · NA · recruiting
- NCT04288531 — Iodine Impact on Thyroid Function and Psychomotor Development, Observational Study in the Portuguese Minho Region · active not recruiting
Other Tufts University trials
Trials by the same sponsor.
- NCT07249242 — Healing Outcomes of Peri-implant Soft Tissues With Different Healing Abutments · NA · recruiting
- NCT07099131 — Effective Interventions to Overcome Severe Gag Reflex · EARLY_PHASE1 · not yet recruiting
- NCT06428630 — Systemic Absorption of Dexamethasone Oral Rinse in Patients With Oral Lichen Planus · EARLY_PHASE1 · withdrawn
- NCT06526221 — Evaluating Urine Isoniazid Testing to Detect Nonadherence to Tuberculosis Medications in India · NA · not yet recruiting
- NCT06352645 — Evaluation of Safety and Efficacy of Bixdo Ultra Compact Water Flosser · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03061409 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tufts University
- Last refreshed: 10 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03061409.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing